Cargando…
A Systematic Literature Review and Bucher Indirect Comparison: Tildrakizumab versus Guselkumab
BACKGROUND: Psoriasis is a chronic inflammatory skin condition that impacts quality of life and requires long-term treatment and effective symptom management. Interleukin-23 (IL-23) has emerged as a key player in the pathogenesis of psoriasis and tildrakizumab and guselkumab are both immunomodulator...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Columbia Data Analytics, LLC
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398610/ https://www.ncbi.nlm.nih.gov/pubmed/32766377 http://dx.doi.org/10.36469/jheor.2020.13671 |